# Zhejiang Huahai Pharmaceutical Co., Ltd., Zhejiang, China – FDA Inspections

Source: https://www.keypedia.com/companies/zhejiang-huahai-pharmaceutical-co-ltd/77f8f66f-ca2e-4b91-b460-a4bd2041c866

> Inspection records and compliance data for Zhejiang Huahai Pharmaceutical Co., Ltd. in Zhejiang, 317024. 11 FDA inspections on record (2 OAI), 5 Form 483s, 1 warning letter, last inspected April 24, 2026.

---

## Details

- Name: Zhejiang Huahai Pharmaceutical Co., Ltd.
- FEI Number: 3003999190
- Facility Type: Finished Dosage Drug and API Manufacturer
- Business Operations: API MANUFACTURE, FDF MANUFACTURE
- Address Line 1: Taizhou
- City: Zhejiang
- State: 317024
- Zip Code: China
- Country Name: China
- Address: Taizhou, Zhejiang, 317024 China, China
- Country: China

## Related Documents

- [483 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2026-04-24](https://www.keypedia.com/records/483/zhejiang-huahai-pharmaceutical-co-ltd/b8364697-ffce-40cd-a7e7-ba3650f1c806) — source: FDA, date: April 24, 2026
- [FDA Inspection 1319736 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2026-04-24](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/63e5b9f3-f398-4916-8957-fca50802a442) — source: FDA, date: April 24, 2026
- [483 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2025-04-16](https://www.keypedia.com/records/483/zhejiang-huahai-pharmaceutical-co-ltd/2ef1cc2c-83c1-438d-977d-2b5e750c3a15) — source: FDA, date: April 16, 2025
- [483 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2025-01-24](https://www.keypedia.com/records/483/zhejiang-huahai-pharmaceutical-co-ltd/2926c83b-9c99-45b2-9b94-43a309b6c6a8) — source: FDA, date: January 24, 2025
- [WARNING_LETTER - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2025-01-24](https://www.keypedia.com/records/warning_letter/zhejiang-huahai-pharmaceutical-co-ltd/47330180-d7a6-4bdf-bf4a-82d60591d4e8) — source: FDA, date: January 24, 2025
- FDA Inspection 1259818 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2025-01-24 — source: FDA, date: January 24, 2025
- [FDA Inspection 1259818 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2025-01-24](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/6c8aed33-ef33-4a48-97c2-992934935373) — classification: Official Action Indicated (OAI), source: FDA, date: January 24, 2025
- FDA Inspection 1149252 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2021-07-02 — classification: No Action Indicated (NAI), source: FDA, date: July 2, 2021
- [483 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2019-06-28](https://www.keypedia.com/records/483/zhejiang-huahai-pharmaceutical-co-ltd/90a0c6c6-2a30-43db-ab08-8293a7514d58) — source: FDA, date: June 28, 2019
- [FDA Inspection 1094941 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2019-06-28](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/df4d4247-aa87-49a8-a139-e03b3c32f929) — source: FDA, date: June 28, 2019
- [483 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2019-05-31](https://www.keypedia.com/records/483/zhejiang-huahai-pharmaceutical-co-ltd/30c96b5f-fed4-4761-bd29-7764a4ff72bf) — source: FDA, date: May 31, 2019
- [FDA Inspection 1093250 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2019-05-31](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/2b5b7233-044f-42f2-ac3f-00e6696bfc49) — classification: Official Action Indicated (OAI), source: FDA, date: May 31, 2019
- FDA Inspection 1042575 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2018-01-26 — source: FDA, date: January 26, 2018
- [EIR - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2017-06-14](https://www.keypedia.com/records/eir/zhejiang-huahai-pharmaceutical-co-ltd/0023ddc0-0940-4327-b448-578395aafe80) — source: FDA, date: June 14, 2017
- FDA Inspection 1018164 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2017-06-14 — source: FDA, date: June 14, 2017
- [483 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2016-11-18](https://www.keypedia.com/records/483/zhejiang-huahai-pharmaceutical-co-ltd/f4b9c8ff-7a62-4903-afaa-573a00330b62) — source: FDA, date: November 18, 2016
- [FDA Inspection 993041 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2016-11-18](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/0b357083-d8c1-4b5b-9169-ab1f1c610575) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 18, 2016
- [FDA Inspection 921574 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2015-03-27](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/98610561-1547-4923-aaf6-de97c6883bb5) — classification: No Action Indicated (NAI), source: FDA, date: March 27, 2015

## Related Companies

- [Chemspec Chemicals Private Limited](https://www.keypedia.com/companies/chemspec-chemicals-private-limited/1146fa48-6575-4871-9f9f-d0123a964d22)
- [Chromo Laboratories India Private Limited](https://www.keypedia.com/companies/chromo-laboratories-india-private-limited/2ad9e1f0-45cb-4dde-bab5-26579c1ca5e2)
- [Medinatura New Mexico, inc.](https://www.keypedia.com/companies/medinatura-new-mexico-inc/9ac6fb13-d04a-47c0-984a-ed542030da80)
- [Novo Nordisk Pharmaceutical Industries LP](https://www.keypedia.com/companies/novo-nordisk-pharmaceutical-industries-lp/ae9a8861-e1ab-4878-a69f-e2f23284d455)
- [Max Chemical Inc](https://www.keypedia.com/companies/max-chemical-inc/622c32f0-42a1-4ae4-aeee-bd9125f0ed89)
- [Les Importations Herbasante Inc.](https://www.keypedia.com/companies/les-importations-herbasante-inc/3d1eca38-4416-426d-a7ef-529d1e50ddf2)
- [SK Biotek Co., Ltd. (Sejong Plant)](https://www.keypedia.com/companies/sk-biotek-co-ltd-sejong-plant/22f4465e-20a8-43d1-9c64-52eacad2d9e4)
- [Hy-Gro Chemicals Pharmtek Pvt. Ltd.](https://www.keypedia.com/companies/hy-gro-chemicals-pharmtek-pvt-ltd/923ed176-9972-4002-9f37-4c4f4e5ab4e1)
- [Regis Technologies, Inc.](https://www.keypedia.com/companies/regis-technologies-inc/b28a19bd-2caa-4023-9b89-ee609c032939)
- [GEO Specialty Chemicals, Inc.](https://www.keypedia.com/companies/geo-specialty-chemicals-inc/05f781e7-99ba-4f36-a5d7-76f1bced9d0a)

## Related Officers

- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)
- [investigator](https://www.keypedia.com/people/jonathan-w-chapman/5b5134c3-71f9-4212-9429-4554d91e8aa9)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [President](https://www.keypedia.com/people/peter-e-baker/c32eb848-de28-4725-80c9-ef8548d445bf)